Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

被引：0
|
作者：
Simon Kind
Franziska Büscheck
Doris Höflmayer
Claudia Hube-Magg
Martina Kluth
Maria Christina Tsourlakis
Stefan Steurer
Till S. Clauditz
Andreas M. Luebke
Eike Burandt
Waldemar Wilczak
Andrea Hinsch
David Dum
Sören Weidemann
Christoph Fraune
Burkhard Beyer
Thomas Steuber
Hartwig Huland
Markus Graefen
Margit Fisch
Ronald Simon
Guido Sauter
Thorsten Schlomm
Sarah Minner
Till Eichenauer
机构：
[1] University Medical Center Hamburg-Eppendorf,Institute of Pathology
[2] University Medical Center Hamburg-Eppendorf,Department of Urology
[3] University Medical Center Hamburg-Eppendorf,Martini
[4] Universitätsmedizin Berlin,Clinic, Prostate Cancer Center
来源：
World Journal of Urology | 2020年 / 38卷
关键词：
Prostate cancer; Prognosis; Claudin-1; Immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2185 / 2196
页数：11
相关论文
共 50 条
  • [41] Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
    Noh, Byeong-Joo
    Sung, Ji-Youn
    Kim, Youn Wha
    Chang, Sung-Goo
    Park, Yong-Koo
    ONCOLOGY LETTERS, 2016, 11 (06) : 3621 - 3630
  • [42] Prognostic Values for ERG, PTEN, CRISP3, and SPINK1 To Predict Biochemical Recurrence in Prostate Cancer
    Noh, Byeong-Joo
    Sung, Ji-Youn
    Kim, Youn-Wha
    Chang, Sung-Goo
    Park, Yong-Koo
    MODERN PATHOLOGY, 2015, 28 : 247A - 248A
  • [43] Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer
    Song, Cheryn
    Kang, Taejin
    Yoo, Sangjun
    Jeong, In Gab
    Ro, Jae Y.
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 168 - 174
  • [44] Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
    Bosas, Paulius
    Zaleskis, Gintaras
    Dabkeviciene, Daiva
    Dobrovolskiene, Neringa
    Mlynska, Agata
    Tikuisis, Renatas
    Ulys, Albertas
    Pasukoniene, Vita
    Jarmalaite, Sonata
    Jankevicius, Feliksas
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [45] SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer
    Hernandez-Llodra, Silvia
    Segales, Laura
    Safont, Ainara
    Juanpere, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Rodriguez-Vida, Alejo
    Cecchini, Lluis
    Bellmunt, Joaquim
    Lloreta-Trull, Josep
    PROSTATE, 2019, 79 (10): : 1156 - 1165
  • [46] Increased Paxillin expression in prostate cancer is associated with advanced pathological features, lymph node metastases and biochemical recurrence
    Zheng, Qing-Shui
    Chen, Shao-Hao
    Wu, Yu-Peng
    Chen, Hui-Jun
    Chen, Hong
    Wei, Yong
    Li, Xiao-Dong
    Huang, Jin-Bei
    Xue, Xue-Yi
    Xu, Ning
    JOURNAL OF CANCER, 2018, 9 (06): : 959 - 967
  • [47] Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence
    Andrew, Angeline S.
    Marsit, Carmen J.
    Schned, Alan R.
    Seigne, John D.
    Kelsey, Karl T.
    Moore, Jason H.
    Perreard, Laurent
    Karagas, Margaret R.
    Sempere, Lorenzo F.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1158 - 1166
  • [48] PREBIOPSY MRI APPROACH FOR PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH LOWER RISK OF BIOCHEMICAL RECURRENCE AFTER TREATMENT
    Blank, Fernando
    Debnath, Neha
    Tayebi, Shima
    Cherry, Amy
    Tobler, Juliana
    Verma, Sadhna
    Sidana, Abhinav
    JOURNAL OF UROLOGY, 2023, 209 : E617 - E617
  • [49] Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
    Burdelski, Christoph
    Strauss, Christian
    Tsourlakis, Maria Christina
    Kluth, Martina
    Hube-Magg, Claudia
    Melling, Nathaniel
    Lebok, Patrick
    Minner, Sarah
    Koop, Christina
    Graefen, Markus
    Heinzer, Hans
    Wittmer, Corinna
    Krech, Till
    Sauter, Guido
    Wilczak, Waldemar
    Simon, Ronald
    Schlomm, Thorsten
    Steurer, Stefan
    ONCOTARGET, 2015, 6 (10) : 8377 - 8387
  • [50] Androgen-responsive PTPN1 immunostaining is associated to biochemical recurrence in prostate cancer
    Nunes-Xavier, C. E.
    Mingo, J.
    Pulido, R.
    Lopez, J. I.
    VIRCHOWS ARCHIV, 2018, 473 : S187 - S188
12345